Search

everythinglearnresearchcommunity

for

Search:↓

Doctors should recognize various nail disorders, new allergens, and metabolic syndrome in patients, and use botulinum toxin carefully in aesthetic procedures.

Insulin resistance and hyperinsulinism are linked to fertility issues and can worsen symptoms of PCOS.

Androgenetic alopecia is linked to family history and androgen effects.

The document concludes that antiandrogenic drugs like cyproterone acetate and spironolactone are effective but not permanent treatments for skin-related androgenization in women.

Spironolactone helps reduce hair growth in women with hirsutism but may cause menstrual irregularities.

Hair loss in women can be caused by genetics, menopause, certain health conditions, and emotional stress, and it often results in thinner hair and a changing hairline.

Six months of treatment improved PCOS symptoms and reduced AMH levels.

Many women with postadolescent acne also have hormonal imbalances and are at higher risk for metabolic issues.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

Taking 5α-reductase inhibitors with prednisolone can worsen its negative effects on metabolism.

Weight loss improves PCOS symptoms and overall health.

The document concludes that accurate diagnosis of male and female gonadal disorders is crucial for effective treatment and better patient outcomes.

Certain natural ingredients and lifestyle changes can help manage PCOS symptoms by balancing hormones and improving insulin sensitivity.

Women with PCOS often have hirsutism and skin changes, which indicate a need for metabolic health checks.

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

The document concludes that more research is needed to include new treatments in guidelines for Polycystic Ovary Syndrome (PCOS).

The document concludes that DNA methylation and the mTOR pathway are important for stem cell function and could impact disease treatment.

A pregnant woman's skin condition improved after giving birth, possibly due to high estrogen levels during pregnancy.

The document says that understanding the causes of PCOS is important for treatment, especially in distinguishing the syndrome from just having cystic ovaries, and that losing weight is key for obese women with PCOS.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Liraglutide caused significant weight loss in some obese women with PCOS, especially those with severe obesity and insulin resistance.

The study found that certain microRNAs are higher in the cells and lower in the fluid of women with a specific type of polycystic ovary syndrome, and one microRNA could potentially help diagnose the condition.

Metformin improves menstrual cycles and hormone levels in women with PCOS, mostly within the first 6 months.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Women with PCOS have higher 5α-reductase activity, which may be linked to insulin resistance.

PCOS symptoms vary by age, affecting diagnosis and treatment.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

The Ayurvedic treatment helped a woman with PCOS, improving her symptoms and menstrual cycle.

Phytotherapeutic compounds and supplements can help manage Polycystic Ovarian Syndrome (PCOS).

Patients with graft-versus-host disease often have nail changes related to the nail matrix, with severity not linked to skin condition.